Baird
777 East Wisconsin Avenue, Milwaukee, WI, 53202, United States
Overview
Baird is an employee-owned wealth management, capital markets, asset management and private equity firm on a mission to provide the best financial advice and service to their clients and be the best place to work for our associates. With offices and operating affiliates in the United States, Europe and Asia, thwy’re dedicated to providing the best investment advice and service to their individual, institutional, corporate and municipal clients.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 9
Sector focus
- Financial Services
Investment portfolio
- Psilera
Participated · Seed · Jul 2021
Psilera is a biopharmaceutical company developing novel neuroplastogens and psychedelic-derived therapies, headquartered in Tampa, Fla. Its lead compound, PSIL-006, is described as a first-in-class neuroplastogen designed to capture therapeutic benefits of traditional psychedelics while minimizing hallucinogenic and cardiovascular effects. The company plans to advance PSIL-006 into first-in-human trials in 2027 and is using its recent financing to support that transition to clinical-stage development. Psilera has secured an NIH award of up to $2 million for IND-enabling studies in alcohol use disorder and executed a strategic licensing agreement with atai Life Sciences (now AtaiBeckley) for a DMT patent portfolio. Recent corporate developments include the appointment of Magali Haas, MD/PhD, as Chief Medical Officer as Psilera scales operations toward clinical milestones.